Coagulation Analyzers at USNH Naples
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) intends to award a sole source contract to Dasit Spa La Fata for Coagulation Analyzers, Reagents, and Consumables at the U.S. Naval Hospital Naples, Italy. This Special Notice serves as a Notice of Intent (NOI) to ensure consistent and uninterrupted capability for routine and STAT coagulation studies. Interested sources are invited to submit capability statements by June 19, 2026, to determine if a competitive procurement is feasible.
Scope of Work
The requirement is for a lease agreement including one (1) primary and one (1) identical back-up fully automated coagulation analyzer system. Key specifications for the analyzers include:
- Automation: Fully automated sample processing with random and STAT access, on-board dilutions.
- Test Menu: Must perform PT/INR, aPTT, Fibrinogen, and D-Dimer.
- Performance: Suitable for mid-volume labs, virtually maintenance-free internal components, throughput up to 100 results/hour (40+ on-board tests).
- Integration: LIS/MHS Genesis interfacing, customized patient reports, positive patient identification via barcode.
- Maintenance & Support: Full-risk maintenance (parts, labor, travel), 24/7/365 emergency support (2-hour telephonic/remote, 48-hour on-site), annual operator training, application support, and Authorization to Operate (ATO) acquisition.
- Supplies: Provision of all necessary reagents, calibrators, quality control materials, and consumables, delivered quarterly with a 10-15% buffer.
- Installation: Contractor responsible for de-installation of current equipment and installation/setup of new equipment.
- Physical/Electrical: Analyzers must fit within a 213 cm x 88 cm space and operate at 220V.
- Quality Assurance: Enrollment in a recognized External Quality Assessment (EQA) Program for Hemostasis testing.
Contract & Timeline
- Type: Special Notice / Notice of Intent (NOI)
- Authority: 41 U.S.C. 1901 (Sole Source)
- Period of Performance: Anticipated twelve (12) months
- Response Due: June 19, 2026, 1:00 PM Eastern Time
- Published: June 5, 2026
Submission & Evaluation
This is not a request for competitive proposals. Interested sources must submit a capability statement (maximum 1 page, 8.5x11 inch, minimum 10-point font) demonstrating management, technical, and cost capabilities. Submissions must be sent via email ONLY to laura.l.powers10.civ@health.mil as a Microsoft Word or Adobe PDF attachment. Responses will be used for informational purposes to assess competition and determine if a competitive procurement is warranted.
Set-Aside
This is a sole source notice. The agency will review capability statements to determine if a competitive procurement or sole source award will proceed.